Princess Maxima Center for Pediatric Oncology
Dr. Claudia Janda is a Principal Investigator at the Princess Máxima Center for Pediatric Oncology in Utrecht, Netherlands, and has more than a decade of experience as a protein biochemist analyzing structure-function relationships of ligand-receptor systems relevant to human health and disease. Prior to the Princess Máxima Center, Dr. Janda was a Co-founder and Senior Scientist at Surrozen. Prior to Surrozen, she was a Research Scientist and Postdoctoral Associate in the laboratory of Prof. K. Christopher Garcia at Stanford University. During her tenure at Stanford, Dr. Janda developed the surrogate Wnt ligand technology behind Surrozen’s platform and published seminal work on the first crystal structure of a Wnt protein bound to the extracellular domain of a Frizzled receptor. Dr. Janda obtained her Ph.D. in Molecular Biology from the Laboratory of Molecular Biology (MRC-LMB), and the University of Cambridge, U.K, and holds a Master of Science from the Swiss Federal Institute of Technology in Zurich. Dr. Janda has authored, or co-authored, dozens of peer-reviewed articles.